These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 34753889)

  • 21. An Immunomodulatory Gallotanin-Rich Fraction From
    Lasso P; Gomez-Cadena A; Urueña C; Donda A; Martinez-Usatorre A; Romero P; Barreto A; Fiorentino S
    Front Immunol; 2020; 11():584959. PubMed ID: 33312174
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Epigenetic Modification of PD-1/PD-L1-Mediated Cancer Immunotherapy against Melanoma.
    Nanamori H; Sawada Y
    Int J Mol Sci; 2022 Jan; 23(3):. PubMed ID: 35163049
    [TBL] [Abstract][Full Text] [Related]  

  • 23. B16 melanoma control by anti-PD-L1 requires CD8+ T cells and NK cells: application of anti-PD-L1 Abs and Trp2 peptide vaccines.
    Ji S; Lee J; Lee ES; Kim DH; Sin JI
    Hum Vaccin Immunother; 2021 Jul; 17(7):1910-1922. PubMed ID: 33522416
    [TBL] [Abstract][Full Text] [Related]  

  • 24. PD-L1 expression in tumor metastasis is different between uveal melanoma and cutaneous melanoma.
    Javed A; Arguello D; Johnston C; Gatalica Z; Terai M; Weight RM; Orloff M; Mastrangelo MJ; Sato T
    Immunotherapy; 2017 Dec; 9(16):1323-1330. PubMed ID: 29185395
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Histone Deacetylase as a Valuable Predictive Biomarker and Therapeutic Target in Immunotherapy for Non-Small Cell Lung Cancer.
    Shin HS; Choi J; Lee J; Lee SY
    Cancer Res Treat; 2022 Apr; 54(2):458-468. PubMed ID: 34517693
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Cilengitide, an αvβ3-integrin inhibitor, enhances the efficacy of anti-programmed cell death-1 therapy in a murine melanoma model.
    Pan X; Yi M; Liu C; Jin Y; Liu B; Hu G; Yuan X
    Bioengineered; 2022 Feb; 13(2):4557-4572. PubMed ID: 35142593
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A Small Molecule Antagonist of PD-1/PD-L1 Interactions Acts as an Immune Checkpoint Inhibitor for NSCLC and Melanoma Immunotherapy.
    Wang Y; Gu T; Tian X; Li W; Zhao R; Yang W; Gao Q; Li T; Shim JH; Zhang C; Liu K; Lee MH
    Front Immunol; 2021; 12():654463. PubMed ID: 34054817
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Tumor-Targeted Chemoimmunotherapy with Immune-Checkpoint Blockade for Enhanced Anti-Melanoma Efficacy.
    Li M; Yang Y; Xu C; Wei J; Liu Y; Cun X; Yu Q; Tang X; Yin S; Zhang Z; He Q
    AAPS J; 2019 Jan; 21(2):18. PubMed ID: 30635795
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Immune profiling of uveal melanoma identifies a potential signature associated with response to immunotherapy.
    Qin Y; Bollin K; de Macedo MP; Carapeto F; Kim KB; Roszik J; Wani KM; Reuben A; Reddy ST; Williams MD; Tetzlaff MT; Wang WL; Gombos DS; Esmaeli B; Lazar AJ; Hwu P; Patel SP
    J Immunother Cancer; 2020 Nov; 8(2):. PubMed ID: 33203661
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Dynamic Observation: Immune-Privileged Microenvironment Limited the Effectiveness of Immunotherapy in an Intraocular Metastasis Mouse Model.
    Tao T; Liu Y; Zhang J; Huang L; Tao Y
    Ophthalmic Res; 2022; 65(5):584-594. PubMed ID: 35398850
    [TBL] [Abstract][Full Text] [Related]  

  • 31. eEF2K promotes PD-L1 stabilization through inactivating GSK3β in melanoma.
    Chen X; Wang K; Jiang S; Sun H; Che X; Zhang M; He J; Wen Y; Liao M; Li X; Zhou X; Song J; Ren X; Yi W; Yang J; Chen X; Yin M; Cheng Y
    J Immunother Cancer; 2022 Mar; 10(3):. PubMed ID: 35347072
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Dissolving microneedles-based programmed delivery system for enhanced chemo-immunotherapy of melanoma.
    Tian Y; Jing H; Wang Q; Hu S; Wu Z; Duan Y
    J Control Release; 2023 Aug; 360():630-646. PubMed ID: 37414221
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Combination of HDAC inhibitor MS-275 and IL-2 increased anti-tumor effect in a melanoma model via activated cytotoxic T cells.
    Kato Y; Yoshino I; Egusa C; Maeda T; Pili R; Tsuboi R
    J Dermatol Sci; 2014 Aug; 75(2):140-7. PubMed ID: 24866536
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Melanoma Cancer Immunotherapy Using PD-L1 siRNA and Imatinib Promotes Cancer-Immunity Cycle.
    Li C; Han X
    Pharm Res; 2020 May; 37(6):109. PubMed ID: 32476052
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Reduced tumorigenicity of B16-F10 mouse melanoma cells transfected with mycobacterial antigen 85A.
    Tarrant JP; Walsh MJ; Blanchard MC; Lee TD; Hoskin DW; Giacomantonio CA
    Int J Oncol; 2004 Dec; 25(6):1693-9. PubMed ID: 15547707
    [TBL] [Abstract][Full Text] [Related]  

  • 36. 2-methoxyestradiol inhibits melanoma cell growth by activating adaptive immunity.
    Hua W; Huang X; Li J; Feng W; Sun Y; Guo C
    Immunopharmacol Immunotoxicol; 2022 Aug; 44(4):541-547. PubMed ID: 35451929
    [No Abstract]   [Full Text] [Related]  

  • 37. HDAC inhibitors enhance the immunotherapy response of melanoma cells.
    Booth L; Roberts JL; Poklepovic A; Kirkwood J; Dent P
    Oncotarget; 2017 Oct; 8(47):83155-83170. PubMed ID: 29137331
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Lymphopenic condition enhanced the antitumor immunity of PD-1-knockout T cells mediated by CRISPR/Cas9 system in malignant melanoma.
    Yang Z; Wu H; Lin Q; Wang X; Kang S
    Immunol Lett; 2022 Oct; 250():15-22. PubMed ID: 36174769
    [TBL] [Abstract][Full Text] [Related]  

  • 39. HDAC inhibition potentiates anti-tumor activity of macrophages and enhances anti-PD-L1-mediated tumor suppression.
    Li X; Su X; Liu R; Pan Y; Fang J; Cao L; Feng C; Shang Q; Chen Y; Shao C; Shi Y
    Oncogene; 2021 Mar; 40(10):1836-1850. PubMed ID: 33564072
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Investigation of the biological effects of anti-cell adhesive synthetic peptides that inhibit experimental metastasis of B16-F10 murine melanoma cells.
    Humphries MJ; Yamada KM; Olden K
    J Clin Invest; 1988 Mar; 81(3):782-90. PubMed ID: 3343338
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.